Logo

Cognoa Signs an Exclusive License Agreement with Stanford for its Google Glass-based Technology for Children with Autism Spectrum Disorder (ASD)

Share this

Cognoa Signs an Exclusive License Agreement with Stanford for its Google Glass-based Technology for Children with Autism Spectrum Disorder (ASD)

Shots:

  • Cognoa to get exclusive license rights for Stanford’s Google Glass-based autism technology to develop & commercialize digital therapies for children with autism spectrum disorder (ASD)
  • The Superpower Glass (SG) intervention deployed via Google Glass and a mobile app is evaluated in 71 children with ASD and resulted in improvement in socialization- play and coping skills than those with SOC for ASD
  • The SG is a wearable intervention which tracks the face- classify emotions- providing two form of cues- first with a green indicator and in second an emoticon appears to the child in real time. Cognoa has also received the US FDA’s BT designation for its first therapeutic device using the technology

Ref: GlobeNewsWire | Image: WSJ

Click here to­ read the full press release 

Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions